U.S., Nov. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07242534) titled 'Effect of Semaglutide on Embryo Quality in Overweight and Obese Patients Undergoing In Vitro Fertilization. A Randomized Controlled Trial' on Nov. 17.
Brief Summary: This is a randomized, controlled clinical trial with a two-sided superiority hypothesis. The study evaluates whether a 12-week pre-treatment with semaglutide prior to ovarian stimulation improves the number of good-quality blastocysts in overweight and obese women undergoing in vitro fertilization (IVF), compared to no pre-treatment.
Study Start Date: Nov., 2025
Study Type: INTERVENTIONAL
Condition:
Infertility
Obesity
Intervention:
DRUG: Semaglutide
Participants...